133 related articles for article (PubMed ID: 31580184)
1. Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.
Gigg J; McEwan F; Smausz R; Neill J; Harte MK
J Psychopharmacol; 2020 Jan; 34(1):115-124. PubMed ID: 31580184
[TBL] [Abstract][Full Text] [Related]
2. Handling prevents and reverses cognitive deficits induced by sub-chronic phencyclidine in a model for schizophrenia in rats.
Landreth K; Burgess M; Watson L; Lorusso JM; Grayson B; Harte MK; Neill JC
Physiol Behav; 2023 May; 263():114117. PubMed ID: 36781093
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal GABA
Neugebauer NM; Miyauchi M; Sato T; Tadano J; Akal H; Ardehali H; Meltzer HY
Behav Brain Res; 2018 Apr; 342():11-18. PubMed ID: 29289597
[TBL] [Abstract][Full Text] [Related]
4. Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.
McLean SL; Harte MK; Neill JC; Young AM
J Psychopharmacol; 2017 Jun; 31(6):660-666. PubMed ID: 28441905
[TBL] [Abstract][Full Text] [Related]
5. Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.
McAllister KA; Mar AC; Theobald DE; Saksida LM; Bussey TJ
Psychopharmacology (Berl); 2015 Nov; 232(21-22):3883-97. PubMed ID: 26194915
[TBL] [Abstract][Full Text] [Related]
6. Aerobic exercise improves memory and prevents cognitive deficits of relevance to schizophrenia in an animal model.
Mitsadali I; Grayson B; Idris NF; Watson L; Burgess M; Neill J
J Psychopharmacol; 2020 Jul; 34(7):695-708. PubMed ID: 32431225
[TBL] [Abstract][Full Text] [Related]
7. TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABA
Rajagopal L; Huang M; Michael E; Kwon S; Meltzer HY
Neuropsychopharmacology; 2018 Nov; 43(12):2468-2477. PubMed ID: 30093697
[TBL] [Abstract][Full Text] [Related]
8. The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia.
Janhunen SK; Svärd H; Talpos J; Kumar G; Steckler T; Plath N; Lerdrup L; Ruby T; Haman M; Wyler R; Ballard TM
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4059-83. PubMed ID: 26070547
[TBL] [Abstract][Full Text] [Related]
9. Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.
Gaskin PL; Toledo-Rodriguez M; Alexander SP; Fone KC
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27382048
[TBL] [Abstract][Full Text] [Related]
10. Failure of NMDA receptor hypofunction to induce a pathological reduction in PV-positive GABAergic cell markers.
Benneyworth MA; Roseman AS; Basu AC; Coyle JT
Neurosci Lett; 2011 Jan; 488(3):267-71. PubMed ID: 21094213
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of antipsychotics on hippocampal presynaptic protein expressions and recognition memory in a schizophrenia model in mice.
Ozdemir H; Ertugrul A; Basar K; Saka E
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):62-8. PubMed ID: 22640753
[TBL] [Abstract][Full Text] [Related]
12. Estradiol and luteinizing hormone regulate recognition memory following subchronic phencyclidine: Evidence for hippocampal GABA action.
Riordan AJ; Schaler AW; Fried J; Paine TA; Thornton JE
Psychoneuroendocrinology; 2018 May; 91():86-94. PubMed ID: 29529524
[TBL] [Abstract][Full Text] [Related]
13. Synaptic transmission changes in fear memory circuits underlie key features of an animal model of schizophrenia.
Pollard M; Varin C; Hrupka B; Pemberton DJ; Steckler T; Shaban H
Behav Brain Res; 2012 Feb; 227(1):184-93. PubMed ID: 22085880
[TBL] [Abstract][Full Text] [Related]
14. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
15. Subchronic PCP effects on DNA methylation and protein expression of NMDA receptor subunit genes in the prefrontal cortex and hippocampus of female rats.
Loureiro CM; Fachim HA; Harte MK; Dalton CF; Reynolds GP
J Psychopharmacol; 2022 Feb; 36(2):238-244. PubMed ID: 35102781
[TBL] [Abstract][Full Text] [Related]
16. Bacopa monnieri (Brahmi) improved novel object recognition task and increased cerebral vesicular glutamate transporter type 3 in sub-chronic phencyclidine rat model of schizophrenia.
Piyabhan P; Wannasiri S; Naowaboot J
Clin Exp Pharmacol Physiol; 2016 Dec; 43(12):1234-1242. PubMed ID: 27562725
[TBL] [Abstract][Full Text] [Related]
17. Modelling the cognitive and neuropathological features of schizophrenia with phencyclidine.
Reynolds GP; Neill JC
J Psychopharmacol; 2016 Nov; 30(11):1141-1144. PubMed ID: 27624147
[TBL] [Abstract][Full Text] [Related]
18. Neurosteroid pregnenolone sulfate, alone, and as augmentation of lurasidone or tandospirone, rescues phencyclidine-induced deficits in cognitive function and social interaction.
Rajagopal L; Soni D; Meltzer HY
Behav Brain Res; 2018 Sep; 350():31-43. PubMed ID: 29763637
[TBL] [Abstract][Full Text] [Related]
19. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia.
Chung DW; Fish KN; Lewis DA
Am J Psychiatry; 2016 Nov; 173(11):1131-1139. PubMed ID: 27444795
[TBL] [Abstract][Full Text] [Related]
20. The involvement of distraction in memory deficits induced by NMDAR antagonism: relevance to cognitive deficits in schizophrenia.
Grayson B; Adamson L; Harte M; Leger M; Marsh S; Piercy C; Neill JC
Behav Brain Res; 2014 Jun; 266():188-92. PubMed ID: 24632009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
